• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突尼斯南部成人戈谢病:三例报告。

Adult Gaucher disease in southern Tunisia: report of three cases.

机构信息

Molecular Investigation of Genetic Orphan Diseases, Pasteur Institute, Tunis - Tunisia.

出版信息

Diagn Pathol. 2012 Jan 10;7:4. doi: 10.1186/1746-1596-7-4.

DOI:10.1186/1746-1596-7-4
PMID:22233685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3275535/
Abstract

BACKGROUND

Gaucher disease (GD) is the most frequent lysosomal storage disorder; type 1 is by far the most common form. It is characterized by variability in age of onset, clinical signs and progression. It is usually diagnosed in the first or second decade of life with the appearance of bone pains, splenomegaly and thrombocytopenia, but the disease may be diagnosed at any age between 1 and 73 years. In the present study, we report 3 cases with late onset of GD in whom the disease was a surprise finding including one patient with Parkinson disease. This late onset is described as an adult form of Gaucher disease.

FINDINGS

Molecular investigation showed mutational homogeneity in Tunisian adult patients suffering from GD. Indeed, all patients carry the p.N370S mutation: two patients at a homozygous state and one patient at compound heterozygous state.

CONCLUSION

The p.N370S mutation presents a large variability in the onset of the disease and its clinical manifestation supporting the view that GD should be considered as a continuum phenotype rather than a predefined classification.

摘要

背景

戈谢病(Gaucher disease,GD)是最常见的溶酶体贮积症;1 型是迄今为止最常见的形式。其发病年龄、临床表现和进展各不相同。它通常在生命的第一个或第二个十年被诊断出来,表现为骨痛、脾肿大和血小板减少症,但该疾病也可能在 1 至 73 岁之间的任何年龄被诊断出来。在本研究中,我们报告了 3 例晚发型 GD 病例,其中疾病的发现令人意外,包括 1 例帕金森病患者。这种晚发型被描述为成人型戈谢病。

结果

分子研究显示突尼斯成年 GD 患者具有突变同源性。事实上,所有患者均携带 p.N370S 突变:2 例为纯合子状态,1 例为复合杂合子状态。

结论

p.N370S 突变在疾病的发病和临床表现上具有很大的变异性,支持将 GD 视为连续表型而不是预先定义的分类的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955b/3275535/e32567e6ffda/1746-1596-7-4-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955b/3275535/e32567e6ffda/1746-1596-7-4-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955b/3275535/e32567e6ffda/1746-1596-7-4-1.jpg

相似文献

1
Adult Gaucher disease in southern Tunisia: report of three cases.突尼斯南部成人戈谢病:三例报告。
Diagn Pathol. 2012 Jan 10;7:4. doi: 10.1186/1746-1596-7-4.
2
High risk screening for Gaucher disease in patients with splenomegaly and/or thrombocytopenia in China: 55 cases identified.中国伴脾大及/或血小板减少的患者行戈谢病高危筛查:发现 55 例。
Clin Chim Acta. 2020 Jul;506:22-27. doi: 10.1016/j.cca.2020.03.016. Epub 2020 Mar 9.
3
Two new mild homozygous mutations in Gaucher disease patients: clinical signs and biochemical analyses.戈谢病患者中的两个新的轻度纯合突变:临床体征和生化分析
Am J Med Genet. 1997 Jun 27;70(4):437-43. doi: 10.1002/(sici)1096-8628(19970627)70:4<437::aid-ajmg19>3.0.co;2-i.
4
The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.N370S型戈谢病未被充分认识的进展性本质及403例患者癌症风险评估
Am J Hematol. 2009 Apr;84(4):208-14. doi: 10.1002/ajh.21362.
5
[Molecular diagnosis of Gaucher disease in Tunisia].
Pathol Biol (Paris). 2013 Apr;61(2):59-63. doi: 10.1016/j.patbio.2012.03.006. Epub 2012 Apr 27.
6
Biochemical and molecular characterization of adult patients with type I Gaucher disease and carrier frequency analysis of Leu444Pro - a common Gaucher disease mutation in India.成年I型戈谢病患者的生化和分子特征以及Leu444Pro(印度常见的戈谢病突变)的携带者频率分析
BMC Med Genet. 2018 Oct 1;19(1):178. doi: 10.1186/s12881-018-0687-5.
7
Type 1 Gaucher disease: significant disease manifestations in "asymptomatic" homozygotes.1型戈谢病:“无症状”纯合子中的显著疾病表现。
Arch Intern Med. 2010 Sep 13;170(16):1463-9. doi: 10.1001/archinternmed.2010.302.
8
Novel mutation, L371V, causing multigenerational Gaucher disease in a Lebanese family.导致一个黎巴嫩家庭出现多代戈谢病的新型突变L371V
Am J Med Genet A. 2004 Mar 15;125A(3):257-60. doi: 10.1002/ajmg.a.20518.
9
Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry.I型戈谢病N370S纯合子的表型异质性:对来自国际戈谢病研究组(ICGG)戈谢病登记处的798例患者的分析
J Inherit Metab Dis. 2008 Dec;31(6):738-44. doi: 10.1007/s10545-008-0868-z. Epub 2008 Nov 3.
10
High prevalence of the 55-bp deletion (c.1263del55) in exon 9 of the glucocerebrosidase gene causing misdiagnosis (for homozygous N370S (c.1226A > G) mutation) in Spanish Gaucher disease patients.在西班牙戈谢病患者中,葡萄糖脑苷脂酶基因第9外显子55碱基对缺失(c.1263del55)的高流行率导致误诊(针对纯合子N370S(c.1226A>G)突变)。
Blood Cells Mol Dis. 2002 Jul-Aug;29(1):35-40. doi: 10.1006/bcmd.2002.0535.

引用本文的文献

1
Genetics and genomic medicine in Tunisia.突尼斯的遗传学与基因组医学。
Mol Genet Genomic Med. 2018 Mar;6(2):134-159. doi: 10.1002/mgg3.392.

本文引用的文献

1
Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population.黏多糖贮积症 IH 型(Hurler 病):突尼斯人群的临床特征和近亲婚配情况。
Diagn Pathol. 2011 Nov 10;6:113. doi: 10.1186/1746-1596-6-113.
2
Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms.突尼斯黏多糖贮积症 I 型的分子分析:新突变的鉴定和 8 个新的多态性。
Diagn Pathol. 2011 Apr 26;6:39. doi: 10.1186/1746-1596-6-39.
3
Type 1 Gaucher disease: significant disease manifestations in "asymptomatic" homozygotes.
1型戈谢病:“无症状”纯合子中的显著疾病表现。
Arch Intern Med. 2010 Sep 13;170(16):1463-9. doi: 10.1001/archinternmed.2010.302.
4
Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa.葡萄糖脑苷脂酶突变不是北非帕金森病的常见危险因素。
Neurosci Lett. 2010 Jun 21;477(2):57-60. doi: 10.1016/j.neulet.2009.11.066. Epub 2009 Nov 27.
5
Gaucher disease in Tunisia: High frequency of the most common mutations.突尼斯的戈谢病:最常见突变的高频率
Blood Cells Mol Dis. 2009 Sep-Oct;43(2):161-2. doi: 10.1016/j.bcmd.2009.05.004. Epub 2009 Jun 23.
6
[Mutation spectrum of Gaucher disease in Tunisia: high frequency of N370S/Rec NciI compound heterozygous].
Arch Inst Pasteur Tunis. 2007;84(1-4):65-70.
7
Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry.I型戈谢病N370S纯合子的表型异质性:对来自国际戈谢病研究组(ICGG)戈谢病登记处的798例患者的分析
J Inherit Metab Dis. 2008 Dec;31(6):738-44. doi: 10.1007/s10545-008-0868-z. Epub 2008 Nov 3.
8
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.与葡糖脑苷脂酶突变相关的帕金森氏症表现谱。
Arch Neurol. 2008 Oct;65(10):1353-7. doi: 10.1001/archneur.65.10.1353.
9
[Biochemical and molecular diagnosis of Gaucher disease in Tunisia].
Ann Biol Clin (Paris). 2007 Nov-Dec;65(6):647-52.
10
Carrier screening for Gaucher disease: more harm than good?戈谢病的携带者筛查:弊大于利?
JAMA. 2007 Sep 19;298(11):1329-31. doi: 10.1001/jama.298.11.1329.